These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies]. Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999 [TBL] [Abstract][Full Text] [Related]
3. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951 [TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
5. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders. Ohshima K; Kikuchi M; Takeshita M J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685 [TBL] [Abstract][Full Text] [Related]
6. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
7. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow]. Marisavljević D; Rolović Z; Mitrović D Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637 [TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders. Chuang SS; Jung YC; Li CY Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451 [TBL] [Abstract][Full Text] [Related]
9. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes. Maratheftis CI; Bolaraki PE; Voulgarelis M Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514 [TBL] [Abstract][Full Text] [Related]
11. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453 [TBL] [Abstract][Full Text] [Related]
12. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Tauro S; Hepburn MD; Bowen DT; Pippard MJ Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409 [TBL] [Abstract][Full Text] [Related]
13. Naked megakaryocyte nuclei in bone marrows of patients with acquired immunodeficiency syndrome: a somewhat specific finding. Gordon S; Lee S Mod Pathol; 1994 Feb; 7(2):166-8. PubMed ID: 8008737 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of Ulex europaeus agglutinin 1 (UEA-1) binding of megakaryocytes in bone marrow biopsy specimens: demonstration of heterogeneity in staining pattern reflecting the stages of differentiation. Liu SM; Li CY Hematopathol Mol Hematol; 1996; 10(1-2):99-109. PubMed ID: 8792151 [TBL] [Abstract][Full Text] [Related]
15. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Ellis JT; Peterson P; Geller SA; Rappaport H Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666 [TBL] [Abstract][Full Text] [Related]
16. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients. Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia. Irvine AE; Magill MK; Somerville LE; McMullin MF Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661 [TBL] [Abstract][Full Text] [Related]
18. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP]. Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085 [TBL] [Abstract][Full Text] [Related]
19. [Histopathologic diagnosis of bone marrow in leukemia and related disorders]. Kikuchi M; Ohshima K; Kobari S Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461 [TBL] [Abstract][Full Text] [Related]
20. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]